These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7363245)
1. Methodologic considerations for trials of lung cancer prophylaxis. Miller AB Can Med Assoc J; 1980 Apr; 122(7):776-9. PubMed ID: 7363245 [TBL] [Abstract][Full Text] [Related]
2. Controlled prophylactic trials in cancer. Magnus K; Miller AB J Natl Cancer Inst; 1980 Apr; 64(4):693-9. PubMed ID: 6928983 [No Abstract] [Full Text] [Related]
4. [Methodology and legitimacy of French clinical trials in primary chemoprevention of cancers. The point of view of the National Federation of French cancer centers]. Eisinger F; Maraninchi D; Philip T Bull Cancer; 1995 Jul; 82 Suppl 3():232s-236s. PubMed ID: 7492838 [TBL] [Abstract][Full Text] [Related]
5. [Ethical and legal problems of medical responsibility in drug trials (author's transl)]. Nicolas F; Nicolas G Anesth Analg (Paris); 1980; 37(9-10):605-6, 609-11. PubMed ID: 7469077 [TBL] [Abstract][Full Text] [Related]
6. Ethical communication in clinical trials. Issues faced by data managers in obtaining informed consent. Loh WY; Butow PN; Brown RF; Boyle F Cancer; 2002 Dec; 95(11):2414-21. PubMed ID: 12436450 [TBL] [Abstract][Full Text] [Related]
7. The ethics of phase 0 oncology trials. Abdoler E; Taylor H; Wendler D Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585 [TBL] [Abstract][Full Text] [Related]
8. Ethical issues in cooperative cancer therapy trials from a statistical viewpoint. II. Specific issues. Shuster JJ; Krischer JP; Boyett JM Am J Pediatr Hematol Oncol; 1985; 7(1):64-70. PubMed ID: 4037245 [TBL] [Abstract][Full Text] [Related]
10. [Modern ethics. Various considerations, particularly based on hospital experience]. Neves C Acta Med Port; 1998 Apr; 11(4):373-7. PubMed ID: 9644849 [TBL] [Abstract][Full Text] [Related]
11. Issues in clinical trials of prophylaxis of fungal infections. Powers JH Clin Infect Dis; 2004 Oct; 39 Suppl 4():S211-7. PubMed ID: 15546120 [TBL] [Abstract][Full Text] [Related]
12. Sequential clinical trials in cancer research. George SL Cancer Treat Rep; 1980; 64(2-3):393-7. PubMed ID: 7407775 [TBL] [Abstract][Full Text] [Related]
13. Phase 0 clinical trials in oncology: a paradigm shift for early drug development? Takimoto CH Cancer Chemother Pharmacol; 2009 Mar; 63(4):703-9. PubMed ID: 18615251 [TBL] [Abstract][Full Text] [Related]
14. [Informed consent in phase I trial]. Shimada Y Gan To Kagaku Ryoho; 1996 Jan; 23(2):226-30. PubMed ID: 8611051 [TBL] [Abstract][Full Text] [Related]
15. Seeking informed consent to cancer clinical trials: describing current practice. Brown RF; Butow PN; Ellis P; Boyle F; Tattersall MH Soc Sci Med; 2004 Jun; 58(12):2445-57. PubMed ID: 15081196 [TBL] [Abstract][Full Text] [Related]
16. [Problems in conducting clinical trials for cancer patients]. Kondo M Gan To Kagaku Ryoho; 1996 Jan; 23(2):151-5. PubMed ID: 8611042 [TBL] [Abstract][Full Text] [Related]
17. End points in cancer clinical trials and the drug approval process. Schilsky RL Clin Cancer Res; 2002 Apr; 8(4):935-8. PubMed ID: 11948095 [TBL] [Abstract][Full Text] [Related]
18. The development of phase I cancer trial methodologies: the use of pharmacokinetic and pharmacodynamic end points sets the scene for phase 0 cancer clinical trials. Calvert AH; Plummer R Clin Cancer Res; 2008 Jun; 14(12):3664-9. PubMed ID: 18559580 [TBL] [Abstract][Full Text] [Related]
19. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
20. Ethical dilemmas encountered during clinical drug trials. Daicos GK Hum Health Care; 2001; 1(2):E9. PubMed ID: 14986633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]